Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
New Studies To Explore Whether Chemicals In Firefighter Foam Contributed To COVID-19 Pandemic March 12, 2021 Irvin Jackson Add Your Comments Researchers plan to conduct three new studies to examine whether toxic chemicals in firefighting foam and other products, known as per and polyfluoroalkyl substances (PFAS), may have contributed to the rapid spread of COVID-19 in the United States, or potentially make vaccines less effective. The studies are being conducted by researchers at the University of Arizona, and are based on previous findings that suggest PFAS exposure can hinder the immune system, making individuals more vulnerable to infections, such as the novel coronavirus, according to a report by Tucson.com. One study, known as Arizona Heroes, will look at data on more than 3,000 firefighters, as well as other first-responders and workers on the front lines of the pandemic. About 1,000 of those first responders either had COVID-19 at the beginning of the study, or contracted it later. The researchers seek to recruit another 1,000 subjects who have had COVID-19 and have not yet been vaccinated. Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Another of the studies, titled Recover, will look at front-line workers nationwide. The third study, Paces, will collect blood from 100 to 120 firefighters in Arizona and Florida who have already had COVID-19, and will measure the levels of PFAS in their blood. Only one similar study has been conducted to date. That was by researchers from Harvard and Denmark, who found those with higher levels of PFAS chemicals in their blood tended to suffer more severe cases of COVID-19. PFAS and Firefighter Foam Environmental Concerns PFAS were first introduced into the manufacturing industry in the 1940’s, because of their ability to resist heat, grease, stains, and water. However, since then the chemicals have been linked to a myriad of adverse health effects including liver damage, thyroid disease, decreased fertility, high cholesterol, obesity, hormone suppression, and cancer. The chemical substances are used to manufacture a number of products, including some firefighting foams, food packaging materials, pizza boxes, popcorn bags, fabrics, nonstick cooking pans, and other products. However, it is perhaps most known for its use in aqueous film-forming foams (AFFFs) used by military and civilian firefighters. The firefighting foam has been regularly used at military bases nationwide over the past decade during routine training and fire extinguishing exercises, and there has been renewed focus on the health risks after the chemicals have been found to contaminate many local water supplies around the training sites. It is projected to take thousands of years for PFAS to degrade, and past studies have shown their ability to enter and stay in the environment and human body through the air, dust, food, soil, and water. Previous U.S. Centers for Disease Control and Prevention (CDC) studies have shown PFAS chemicals primarily settle into the blood, kidney and liver, and could likely be detected in the blood of 98% of the U.S. population. Chemical manufacturers now face a growing number of firefighting foam lawsuits brought by individuals nationwide, including former fire fighters diagnosed with cancer and individuals who lived near military bases or training facilities where chemicals from the toxic foam contaminated drinking water supplies. Tags: Arizona, Coronavirus, Firefighting Foam, Infections, PFAS Find Out If You Qualify for A AFFF Lawsuit Settlement More Firefighting Foam Lawsuit Stories Link Between AFFF and Liver Cancer, Thyroid Cancer To Be Examined by MDL Court February 17, 2025 PFAS Risks From Firefighting Foam Were Known by 3M for Decades: Guardian Report January 20, 2025 PFAS in Drinking Water Linked to Certain Forms of Cancer: Study January 16, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: today) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025) Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 3 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024) Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (Posted: 4 days ago) A federal judge has ordered lawyers involved in Bard PowerPort lawsuits to submit a joint proposal for preparing the first cases for bellwether trials by March 18. MORE ABOUT: BARD POWERPORT LAWSUITE. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)AngioDynamics Seeks to Have Many Chemo Port Lawsuits Dismissed, Arguing Lawsuits Were Filed Too Long After Implant Failed (02/25/2025)AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal (02/18/2025)
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: today) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025)
Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 3 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)
Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (Posted: 4 days ago) A federal judge has ordered lawyers involved in Bard PowerPort lawsuits to submit a joint proposal for preparing the first cases for bellwether trials by March 18. MORE ABOUT: BARD POWERPORT LAWSUITE. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)AngioDynamics Seeks to Have Many Chemo Port Lawsuits Dismissed, Arguing Lawsuits Were Filed Too Long After Implant Failed (02/25/2025)AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal (02/18/2025)